Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Investor Alert: Update in Lawsuit

A lawsuit is pending on behalf of investors in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) shares over alleged securities laws.

San Diego, CA — (SBWIRE) — 02/15/2022 — The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors, who purchased shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI).

Investors who purchased shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) have certain options and for certain investors are short and strict deadlines running. Deadline: November 1, 2021. NASDAQ: SPPI investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

On August 31, 2021, a lawsuit was filed against Spectrum Pharmaceuticals, Inc. over securities laws violations. The plaintiff claims that between December 27, 2018 and August 5, 2021, the Defendants made false and/or misleading statements and/or failed to disclose that the ROLONTIS manufacturing facility maintained deficient controls and/or procedures, that the foregoing deficiencies decreased the likelihood that the FDA would approve the ROLONTIS BLA in its current form, that Spectrum had therefore materially overstated the ROLONTIS BLA’s approval prospects, and that as a result, the Company’s public statements were materially false and misleading at all relevant times.

In November 2021, several investors filed motions to be a pointed to represent investors affected by the filed lawsuit.

Those who purchased shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.sbwire.com/press-releases/spectrum-pharmaceuticals-inc-nasdaqsppi-investor-alert-update-in-lawsuit-1353313.htm

Media Relations Contact

Michael Daniels
Shareholders Foundation
Telephone: 1-858-779-1554
Email: Click to Email Michael Daniels
Web: https://www.shareholdersfoundation.com/